Renal toxic ingredients and their toxicology from traditional Chinese medicine

Expert Opinion on Drug Metabolism and Toxicology

Volumn 12, Issue 2, 2016, Pages 149-159

  Xu, Xi Lin ^a   Yang, Lin Jiang ^a   Jiang, Jian Guo ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

AAS; alkaloids; renal toxicity; toxicology; Traditional Chinese medicines

Indexed keywords

ACONITINE; ALKALOID; ANTHRAQUINONE DERIVATIVE; ARISTOLOCHIC ACID; BRUCINE; ESCULENTOSIDE A; FLAVONOID; GLYCOSIDE; STRYCHNINE; UNCLASSIFIED DRUG; HERBACEOUS AGENT;

ACONITUM CARMICHAELII; ARISTOLOCHIA; ARISTOLOCHIA CATHCARTII; ARISTOLOCHIA CONTORTA; ARISTOLOCHIA MANSHURIENSIS; CELL TRANSDIFFERENTIATION; CHINESE MEDICINE; CLEMATIS; CLEMATIS CHINENSIS; EPITHELIUM CELL; HUMAN; INFLAMMATION; KIDNEY TUBULE CELL; LEONURUS; LEONURUS TATARICUS; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; REVIEW; STEPHANIA TETRANDRA; STRYCHNOS NUX VOMICA; TRIPTERYGIUM; TRIPTERYGIUM REGELII; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; KIDNEY DISEASE; PROCEDURES;

ANIMALS; DRUGS, CHINESE HERBAL; HUMANS; KIDNEY DISEASES; MEDICINE, CHINESE TRADITIONAL;

EID: 84957442329     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2016.1132306     Document Type: Review

References (101)

1. Ko RJ. A U.S. perspective on the adverse reactions from traditional Chinese medicines. J Chin Med Association. Food Chem Toxicol. 2004;67:109-116.
2. Chang LC, Huang N, Chou YJ, et al. Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population- based study from 1997 to 2003. BMC Health Serv Res. 2008;8:170.
3. Cortes N, Posada D, Alvarez R, et al. Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: a comparative study. J Life Sci. 2015;122:42-50.
4. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol. 2005;43:901-910.
5. Zeng ZP, Jiang JG. Analysis of the adverse reactions induced by natural product derived drugs. Br J Pharmacol. 2010;159:1374-1391.
6. Huang SH, Tung CW, Ferenc F, et al. Developing a QSAR model for hepatotoxicity screening of the active compounds in traditional Chinese medicines. Food and Chem Toxicol. 2015;78:71-77.
7. Qu LP, Zou WJ, Zhou ZX, et al. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective. J Ethnopharmacol. 2014;156:107-114.
8. Lee WM. Drug-induced hepatotoxicity. New England J Med. 2003;349:474-485.
9. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008;74:158-169.
10. Vanherweghem JL. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium. J Altern Complement Med. 1998;4:9-13.
11. Izumotani T, Ishimura E, Tsumura K, et al. An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs. Nephron. 1993;65:137-140.
12. Rao XR, Li S, Li XY, et al. Analysis of two notices on kidney were damaged by herbs containing aristolochic acid from US FDA. Chin J Inf TCM. 2001;8:82-86.
13. Zinchenko OA, Marchenko SV, Sergeyeva A, et al. Application of creatinine-sensitive biosensor for hemodialysis control. Biosens Bioelectron. 2012;35:466-469.
14. Ye YH, Lee YT, Huang S, et al. Short-term toxicity of aristolochic acid, aristolochic acid-I and aristolochic acid-II in rats. Food Chem Toxicol. 2008;46:1157-1163.
15. Bakhiya N, Arlt M, Bahn A, et al. Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy. Toxicology. 2009;264:74-79.
16. Kumar V, Prasad AK, Parmar VS. Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities. Nat Prod Rep. 2004;20:565-583.
17. Li J, Zhang L, Jiang Z, et al. Toxicities of aristolochic acid I and aristololactam I in cultured renal epithelial cells. Toxicol Vitro. 2010;24:1092-1097.
18. Debelle FD, Nortier JL, Garbar CH, et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. Am Soc Nephrol. 2002;13:431-436.
19. Wang SX, Zuo W, Feng JM, et al. Preliminary study of immune pathological mechanism underlying a mouse model of aristolochic acid nephropathy. Chin Arch Traditional Chin Med. 2003;21:1084-1085.
20. Yuan HW, Zhao CM. Clinical and pathology research of aristolochic acid nephropathy. Guide Chin Med. 2013;11:425-426.
21. Wang NS. Research progress of aristolochic acid renal toxicity. Traditional Chin Drug Res Clin Pharmacol. 2001;12:394-395.
22. Li B, Li XM, Zhang CY. Cellular mechanism of renal proximal tubular epithelial cell injury induced by aristolochicacid I and aristololactam I. J Peking Univ(Health Sciences). 2004;36:36-40.
23. Song LQ, Wang XP, Ma YC, et al. The experimental study of the effects on rat kidney caused by different dosage forms of Aristolochia debilis Sieb.et Zucc and complex prescription contains Aristolochia debilis Sieb.et Zucc. Chin J Integr Traditional West Nephrol. 2008;9:57-58.
24. Liang Q, Ni C, Yan XZ, et al. Nephrotoxicity study of Aristolochia fangchi in rats by metabonomics. China J Chin Materia Med. 2010;35:2882-2888.
25. Sun K, Wu JH. Modern research development of fangchi. Chin Foreign Med Res. 2012;10:157-158.
26. Ding XS, Liang AH, Wang JH, et al. Nephrotoxicity of Aristolochia manshuriensis and aristolochic acids in mice. China J Chin Materia Med. 2005;13:1019-1022.
27. Ma HM, Zhang BL, Xu ZP, et al. Experimental studies on nephrotoxic mechanism of Caulis aristolochiae manshuriensis. Traditional Chin Drug Res Clin Pharmacol. 2001;12:404-9+449-50.
28. Zhong F. Pathogenesis of renal injury caused by aristolochia. Wuhan: Hubei University of Chinese Medicine; 2007.
29. Jiang GZ, Chen L, New research progress of toxicity of aristolochic acid in traditional Chinese medicine. Chin Agric Sci Bull. 2008;24:84-87.
30. Huang RF, Shi W, Wu JY, et al. Acute aristolochic acid nephropathy due to kaempfer dutchmanspipe root poisoning. Adverse Drug React J. 2007;9:412-413.
31. Jin ZH, Zhou WJ, Peng W, et al. Experimental study on chronic renal interstitial fibrosis induced by aristolochic acid in aristolochiae mollissimae herba in rats. Chin J Integr Traditional West Nephrol. 2012;13:299-305.
32. Ma YC, Feng L, Song LQ, et al. Influence of different dosage clematic chinensis osbeck on rat renal function and histology. Chin J Inf TCM. 2004;11:770-772.
33. Xu JB, Wen Z, Yang GZ, et al. Research progress of asarum toxicity. Med J China. 2011;23:2473-2475.
34. Cosyns JP, Jadoul M, Squifflet JP, et al. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis. 1999;33:1011-1017.
35. Katsoulieris E, Mabley JG, Samai M, et al. Lipotoxicity in renal proximal tubular cells: relationship between endoplasmic reticulum stress and oxidative stress pathways. Free Radic Biol Med. 2010;48:1654-1662.
36. Zhu SH, Wang YJ, Li M, et al. Endoplasmic reticulum stress mediates aristolochic acid I-induced apoptosis in human renal proximal tubular epithelial cells. Toxicol Vitro. 2012;26:542-546.
37. Xie J, Guo Q. Apoptosis antagonizing transcription factor protects renal tubule cells against oxidative damage and apoptosis induced by ischemia-reperfusion. Am Soc Nephrol. 2006;17:3336-3346.
38. Ji WX, Huan JY, Meng DM, et al. Effect of aristolochic acid on renal tubular epithelial cells oxidative stress. Shandong Med J. 2011;51:98-100.
39. Li L. Research on strychni toxicology and attenuated. Shanxi J Traditional Chin Med. 2011;27:37-38.
40. Yin G, Liu Z, Liu ZH, et al. Effects of a previous history of renal basic disease on clinical manifestation and pathological changes in patients with aristolochic acid nephropathy. Med J Natl Defending Forces China. 2010;20:135-137.
41. Zuo W, Liu YG, Wang JH, et al. Characteristics and significance of inflammatory cell infiltration of aristolochic acid nephropathy in rat model. J Cell Mol Immunol. 2005;21:98-100.
42. Sun JX. Preliminary study of immune pathological mechanism underlying a mouse model of aristolochic acid nephropathy. Suzhou: Soochow University; 2008.
43. Pozdzik A, Salmon IJ, Husson CP, et al. Pattern of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol Dial Transpl. 2008;23:2480-2491.
44. Xiong JY, Tan ZH. Related mechanisms and main toxic effects of aristolochic acid. J Sichuan Traditional Chin Med. 2011;29:39-42.
45. Wang YY, Zhang ZW, Shen H, et al. TGF-β1/Smad7 signaling stimulates renal tubulointerstitial fibrosis induced by AAI. J Recept Signal Transduct. 2008;28:413-428.
46. Yang L, Li XM, Wang HY. Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis. Nephrol Dial Transpl. 2006;22:445-456.
47. Niu XQ, Chen N, Liu Z, et al. Changes of serumTGF-β1 BMP- 7 in patients with chronic aristolochic acid nephropathy. Heilongjiang Med Pharm. 2012;35:34-35.
48. Wen YJ, Qu L, Li XM. Ischemic injury underlies the pathogenesis of aristolochic acid-induced acute kidney injury. Translational Res. 2008;152:38-46.
49. Peng JL, Bian YH, Wang L, et al. Research progress of aristolochic acid renal toxicity. Global Traditional Chin Med. 2013;6:59-64.
50. Cordell GA, Quinn-Beattie ML, Farnsworth NR. The potential of alkaloids in drug discovery. Phytother Res. 2001;15:183-205.
51. Sun R, Wu XD, Liu JW, et al. Experimental study of the rat renal toxicity of Tripterygium wilfordii, Caulis aritolochiae and Leonurus. Pharmacol Clin Chin Materia Med. 2005;21:26-28.
52. Gao Y, Yu WT, She DL, et al. Recent advancements in toxicity mechanism of Tripterygium wilfordii. Lishizhen Med Materia Med Res. 2011;22:2265-2266.
53. Kun XB, Liu YM. Advances of studies on chemical composition and pharmacological activity of chimonanthus lindl. Res Pract Chin Medicines. 2003;17:59-61.
54. Cai ZY, Zhou JM, Ge YR. Influence of high-dose tetrandra on rat renal function and tissue morphology. Chin J Hosp Pharm. 2005;25:1200-1201.
55. Zhang LM, Yang Q, Qian XL, et al. Experimental study on chronic toxicity in rats caused by different components of rhizoma menispermi. Chin J Pharmacovigilance. 2011;8:129-134.
56. Chen YS, Han QG. Nephrotoxicity of Chinese herbal medicine. Chin J Integr TraditionalWest Nephrol. 2001;2:303-306.
57. Zhao Y, Lu GC, Zhang WD, et al. Advanced study on toxicology of veratrum alkaloids. J Toxicol. 2007;21:310-311.
58. Yang WB, Wang P, Research progress in chemical components, pharmacological effectiveness and toxicity of aconitine. Lishizhen Med Materia Med Res. 2014;25:427-429.
59. Feng Q, Li XY, Sun R. Advance research on pharmacological effect and toxicity of Senecio scandens. Chin J Pharmacovigilance. 2014;11:151-153.
60. Bo S, Ling L, Wu Q, et al. Metabolomic analysis of biofluids from rats treated with aconitum alkaloids using nuclear magnetic resonance and gas chromatography/time-of-flight mass spectrometry. Anal Biochem. 2009;395:362-366.
61. Vichasilp C, Nakagawa K, Sookwong P, et al. Optimization of 1-deoxynojirimycin extraction from mulberry leaves by using response surface methodology. Biosci Biotechnol Biochem. 2009;73:2386-2389.
62. Lei HC, Jh YI. Observation of apoptasis in renal tubule epithelial cell after aconitine poisoning. Ind Health Occup Dis. 2005;31:83-85.
63. Chen YJ, Wu R, Huang XH. Cardiac death and apoptosis of myocardium. J Forensic Med. 1999;15:133-134.
64. Cheng YB, Liu NG, Zhang JH, et al. Apoptosis in mouse after tetramine poisoning. J Forersic Med. 2002;18:137-9+143-93.
65. Zhou WJ. Research and reflection on aristolochic acid renal toxicity. Guangming J Chin Med. 2008;23:1387-1388.
66. Yu X, Li S, Tao JL, et al. Protective effects of BMP-7 against aristolochic acid-induced apoptosis of renal tubular epithelial cells. Guangdong Med J. 2011;32:821-823.
67. Wang ZH, Zhang JL, He Y, et al. Determination of triptolide and triptonide in plasma by HPLC. Chin J Forensic Med. 2004;19:268-270.
68. Guo YH, Tan K. Research on tripterygium toxicity. J Chin Med Mater. 2007;30:112-117.
69. Lin CC, Fan HY, Kuo CW, et al. Evaluation of Chineseherbal- medicine-induced herb-drug interactions: focusing on organic anion transporter 1. Evidence-Based Complement Altern Med. 2012;2012:2-12.
70. Sun C. Effects of eighteen kinds of nephrotoxic Chinese drugs on three major types of organic anion transporters, Oat1, Oat2 and Oat3 and drug metabolizing enzymes of Cyp3a, Cyp2e1 in vivo in mice. J Guangzhou Univ Chin Med. 2014;2:7-8.
71. Wan L, Zhou ZH. Advanced studies on pharmacology of croton. Jiangsu J Traditional Chin Med. 2003;24:60-61.
72. Li KH, Yin YS, Wei JZ, et al. A clinical study to blood purification and glucocorticoid in the rescue acute renal failure because of toadstool. Acta Medicinae Sinica. 2009;22:820-822.
73. Gao P, Sui HX, Liu HB, et al. A 90 day subchronic toxicity study on semen cassiae ethanol extract. Chin J Food Hyg. 2004;16:410-415.
74. Li RQ, Zhang YM, Yu DJ, et al. Empirical study of acute toxicity on Folium Sennae extractive. Mod J Integr Traditional Chin West Med. 2008;17:820-822.
75. Ren HB, Wang Y, Wang TJ. Rhubarb total anthraquinone to rat acute renal toxicity research. J Liaoning Univ Traditional Chin Med. 2012;14:69-71.
76. Zong Q, Tang YP, Shen XC, et al. Research progress on toxic effects of Chinese herbal medicines of Euphorbiaceae. J Nanjing Univ Traditional Chin Med. 2008;24:283-285.
77. Xu X, Xu MS, Zhu JH, et al. Pathological changes in rats with acute Dysosma versipellis poisoning. J Forensic Med. 2013;29:333-336.
78. Fan Z. Modern research progress of toxicity of alismatis rhizoma. Global Traditional Chin Med. 2014;7:155-157.
79. Sui LC, Dai XD. Experimental study on the long-term toxicity of intravenous injection of Brucea javanica oil emulsion. Hainan Med J. 2013;24:1261-1263.
80. Zhang YS, Liu YQ, Wu ZL, et al. Experimental study on nephrotoxicity of bakuchiol to rats. China J Chin Materia Med. 1981;3:30-32.
81. Wang B, Yang HJ, Gao SR, et al. The pathological observation of toxicity on kidney and haper by fructus gardeniae in rats. Chin J Exp Traditional Med Formulae. 2007;13:45-48.
82. Xu YX, Cong L. Reports on poisoning of cottonseed oil. Pub Med For Mag. 2009;13:576-579.
83. Deng YR, Huang XM, Yu MR. Experimental research on acute oral and abdominal cavity toxicities of SQS in mice. Strait Pharm J. 2011;23:25-27.
84. Zhou Q, Yao GT, Jin RM, et al. Study on renal cell toxicity induced by esculentoside A. World Chin Med. 2014;2:151-154.
85. Fang GX, Shi JL, Chen KZ. Renal damage induced by Chinese herbal medicine. J Chin Physician. 2006;40:10-16.
86. Cosyns JP, Jadoul M, Squifflet JP, et al. Chinese herbs nephropathy: a clue to balkan endemic nephropathy. Kidney Int. 1994;45:1680-1688.
87. Cai ZY, Zhou JM, Ge YZ. Influence of motherwort on renal function and tissues in rats. Shanghai J Traditional Chin Med. 2000;11:37-39.
88. Zhang L, Yan JB, Liu XM, et al. Pharmacovigilance practice and risk control of traditional Chinese medicine drugs in China: current status and future perspective. J Ethnopharmacol. 2012;140:519-525.
89. Shaw D, Ladds G, Duez P, et al. Pharmacovigilance of herbal medicine. J Ethnopharmacol. 2012;140:513-518.
90. Zhang L, Yang XH. Pharmacovigilance should be introduced into the safety monitoring and evaluation of traditional Chinese drugs. J Integr Traditional West Med. 2009;29:863-866.
91. Stengel B. Chronic kidney disease and cancer: A troubling connection. J Nephrol. 2010;23:253-262.
92. Yang HY, Wang JD, Lo TC, et al. Occupational kidney disease among Chinese herbalists exposed to herbs containing aristolochic acids. Occup Environ Med. 2011;68:286-290.
93. Arlt VM, Levova K, Barta F, et al. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1 (-/-), Cyp1a2(-/-), and Cyp1a1/1a2(-/-) mice. Chem Res Toxicol. 2011;24:1710-1719.
94. Levova K, Moserova M, Kotrbova V, et al. Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model. Toxicol Sci. 2011;121:43-56.
95. Wang WY, Li XH. Side effects of some Chinese herbs on renal toxicity and its prevention and treatment. LiShiZhen Med Materia Med Res. 2000;4:347-348.
96. Wang K, Feng C, Li CG, et al. Baicalin protects mice from aristolochic acid I-induced kidney injury by induction of CYP1A through the aromatic hydrocarbon receptor. Int J Mol Sci. 2015;16:16454-16468.
97. Michl J, Ingrouille MJ, Simmonds MS, et al. Naturally occurring aristolochic acid analogues and their toxicities. Nat Prod Rep. 2014;31:676-693.
98. Jia X, Li W, Li JS, et al. Progressive studies on toxicity of Strychons nux-vomica. China J Chin Materia Med. 2009;34:2396-2399.
99. Li XW, Yokota S, Wang D, et al. Localization of aristolochic acid in mouse kidney tissues by immunohistochemistry using an anti-AA-I and AA-II monoclonal antibody. Am Journal Chin Medicine. 2014;42:1453-1469.
100. Malone MH, John KM, Bejar E. Brucine lethality in mice. J Ethnopharmacol. 1992;35:295-297.
101. Ye L. Progressive studies on adverse reactions of tripterygium and attenuated. Shandong J Traditional Chin Med. 2010;29:653-655.